Knowledge (XXG)

Template:Uterotonics

Source 📝

198: 37: 241: 325: 215: 30: 320: 166: 203: 114: 174: 147: 93: 99: 67: 15: 133: 245: 50: 209: 76: 314: 255: 109: 84: 58: 184: 138: 123: 89: 179: 152: 46: 128: 54: 283:
will show the template collapsed, i.e. hidden apart from its title bar.
248:), it is hidden apart from its title bar; if not, it is fully visible. 240:, meaning that if there is another collapsible item on the page (a 19: 307:
will show the template expanded, i.e. fully visible.
286: 262: 165: 108: 75: 66: 251:To change this template's initial visibility, the 31: 8: 72: 38: 24: 16: 235:initial visibility currently defaults to 252: 7: 246:table with the collapsible attribute 14: 1: 342: 193: 326:Drug templates by ATC 167:Contraction induction 220:Never to phase III 230: 229: 161: 160: 100:Methylergometrine 68:Cervical ripening 333: 306: 305: 301: 298: 295: 292: 289: 282: 281: 277: 274: 271: 268: 265: 254: 253:|state= 238: 233:This template's 73: 40: 33: 26: 17: 341: 340: 336: 335: 334: 332: 331: 330: 321:Obstetric drugs 311: 310: 303: 299: 296: 293: 290: 287: 279: 275: 272: 269: 266: 263: 242:navbox, sidebar 236: 231: 226: 225: 210:Clinical trials 189: 157: 141: 134:Dinoprostone/E2 113: 104: 77:Ergot alkaloids 62: 44: 12: 11: 5: 339: 337: 329: 328: 323: 313: 312: 309: 308: 284: 228: 227: 224: 223: 222: 221: 218: 207: 201: 195: 194: 191: 190: 188: 187: 182: 177: 171: 169: 163: 162: 159: 158: 156: 155: 153:Carboprost/F2α 150: 143: 142: 139:Sulprostone/E2 136: 131: 126: 124:Misoprostol/E1 119: 117: 110:Prostaglandins 106: 105: 103: 102: 97: 87: 81: 79: 70: 64: 63: 51:labor inducers 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 338: 327: 324: 322: 319: 318: 316: 285: 261: 260: 259: 258:may be used: 257: 249: 247: 243: 239: 219: 217: 214: 213: 211: 208: 205: 202: 200: 197: 196: 192: 186: 183: 181: 178: 176: 173: 172: 170: 168: 164: 154: 151: 149: 148:Dinoprost/F2α 145: 144: 140: 137: 135: 132: 130: 127: 125: 121: 120: 118: 116: 111: 107: 101: 98: 95: 91: 88: 86: 83: 82: 80: 78: 74: 71: 69: 65: 60: 56: 52: 48: 41: 36: 34: 29: 27: 22: 21: 18: 250: 237:autocollapse 234: 232: 129:Gemeprost/E1 94:Syntometrine 85:Acetergamine 23: 291:Uterotonics 267:Uterotonics 206:from market 185:Demoxytocin 90:Ergometrine 47:Uterotonics 315:Categories 180:Carbetocin 278:collapsed 256:parameter 216:Phase III 204:Withdrawn 115:analogues 55:oxytocics 302:expanded 175:Oxytocin 199:WHO-EM 297:state 273:state 244:, or 59:G02A 146:F: 122:E: 112:and 317:: 304:}} 288:{{ 280:}} 264:{{ 212:: 300:= 294:| 276:= 270:| 96:) 92:( 61:) 57:( 53:/ 49:/ 39:e 32:t 25:v

Index

v
t
e
Uterotonics
labor inducers
oxytocics
G02A
Cervical ripening
Ergot alkaloids
Acetergamine
Ergometrine
Syntometrine
Methylergometrine
Prostaglandins
analogues
Misoprostol/E1
Gemeprost/E1
Dinoprostone/E2
Sulprostone/E2
Dinoprost/F2α
Carboprost/F2α
Contraction induction
Oxytocin
Carbetocin
Demoxytocin
WHO-EM
Withdrawn
Clinical trials
Phase III
navbox, sidebar

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.